Delivery Order SPE2DB20D2104-SPE2DB22FT02C

Award Date 6/15/22
Potential Completion Date 6/16/22
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.65 firm-fixed-price delivery order is for the supply of Mirtazapine 7.5 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of 4,564,580,733 units of the prescription drug mirtazapine 15 mg tablets to the Defense Logistics Agency (DLA). The $3,034.25 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,144.24 Firm Fixed Price delivery order is for the supply of 4,554,483,108 units of Mirtazapine 30mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.88 firm fixed-price delivery order is for the supply of 4,567,724,925 units of the pharmaceutical drug mirtazapine 7.5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Mirtazapine 15 mg tablets to the Defense Logistics Agency (DLA). The $2,732.17 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2022 with a completion date of March 15, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,023.17 firm-fixed-price delivery order is for the supply of 1,000 units of Mirtazapine 30 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FE9R2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,230.61 firm-fixed-price delivery order contract is for the supply of 4562953258 - Mirtazapine 7.5 mg tablets in 30-count packages. The contract has an ultimate completion date of December 1, 2023 and was awarded on November 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $1,263.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Mirtazapine 7.5 mg tablets, a medication used to treat mental health conditions. The contract has a completion date of June 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D3102|SPE2DB24FK8RL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,748.61 firm fixed-price delivery order is for the supply of 4,562,525,432 units of the prescription medication Mirtazapine 30 mg tablets. The contract has an ultimate completion date of October 19, 2023 and was awarded on October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,089.89, is for the delivery of 4,563,718,136 tablets of the medication mirtazapine 30 mg, with a completion date of February 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FT02C
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mirtazapine 7.5 mg tablets. The $2,281.84 firm-fixed-price delivery order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical care items, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 11:18 AM